Indian pharma’s US tripping benefits MNCs, Business Standard, July 07, 2014
Med representative’s job partly vanishing, Business Standard, October 16, 2013
Blow to another MNC as patent for GSK’s drug revoked, Business Standard, August 3, 2013
Domestic drug prices immune to pharma acquisitions, The Financial Express, June 12, 2013
Ranbaxy case may take a toll on other Indian drug makers, Business Standard, May 24, 2013
Indian pharma under the microscope, Mint (WSJ), May 24, 2013
New drug policy to negatively impact pharma sector: Industry, Economic Times, May 17, 2013
New drug policy to hit profitability of firms, Business Today, May 17, 2013
Pharma giants may go slow on Indian R&D, The Financial Express, April 4, 2013
Activists, patients’ bodies hail patent ruling
Industry rings a warning, The Telegraph, April 2, 2013
Union Budget 2013 – Dashed hopes, Express Pharma, March 13, 2013
Nothing significant in this budget for the healthcare sector: Tapan Ray, Business Today, March 1, 2013
Budget Reactions: NRUHM only cheer in pharma-silent Budget: Pharma body, Moneycontrol.com, March 1, 2013
Mixed reactions to the budget 2013-14, Pharmabiz, March 01, 2013
India Plans Price Controls for Patented Drugs, The Wall Street Journal, February 27, 2013
Compulsory licenses may spur more voluntary licensing deals, Mint (WSJ), January 25, 2013
India Battles For Right To Use Compulsory Licenses To Make Medicines Affordable,
Third World Network on Intellectual Property Issues, 22 January 2013
2013: A year of short-term pain, for long-term gain? Express Pharma, December 31, 2012
Poor may suffer as India caps drug prices, Nature, December 14, 2012
New drug pricing policy may hit profitability of firms, Live Mint, WSJ, December 11, 2012
Novartis vs India – Supreme Court hearing ends, Express Pharma, December 5, 2012
Big Pharma on the backfoot in India, Business Today, November 30, 2012
New drug policy will hurt investment in pharma sector: Industry, NDTV Profit, November 25, 2012
New drug policy will hurt investment in pharma: Industry, MoneyControl.com, November 25, 2012
‘New drug policy will hurt Pharma sector’, The Indian Express, November 25, 2012
New drug policy will hurt investment in pharma sector: Industry, Economic Times, November 25, 2012
New drug policy will hurt investments in the sector, Business Standarf, November 25, 2012
On The Freeway To Health, Businessworld, November 9, 2012
SC Asks Centre Not To Alter Drug Pricing System, Businessworld, October 3, 2012
Price control list may have 274 more drugs, DNA, September 27, 2012
GoM Nod to Bring 348 Essential Drugs Under Govt Control, Outlook, September 28, 2012
New policy prescription: price control on 348 drugs, Financial Chronicle, September 28, 2012
Commonly used drugs may get cheaper, Live Mint, September 28, 2012
GoM finalises pricing policy for 348 drugs, The Economic Times, September 28, 2012
GoM finalises pharma pricing policy, to cover 348 drugs, Zee Business, September 28, 2012
Unavailability of products with chemists concerning: report, The Economic Times, September 17, 2012
The big pharma feud, The Times of India, Crest Edition, September 15, 2012
Pricing of imported drugs under regulatory scanner, Economic Times, September 6, 2012
India Looks To Expand Drug-Price Controls, Wall Street Journal, September 5, 2012
FDI tangle: And the vote goes to….?, Express Pharma, August 27, 2012
Gearing up for the biosimilar boom, Express Pharma, August 21, 2012
Improving access, innovation, reach key to achieving UHC , Express Pharma, August 21, 2012
Novartis Fights India for Cancer Pill Patent, The Wall Street Journal, August 19, 2012
Big Pharma lobbies hard to curb generics, Times of India, August 16, 2012
Free generics for India’s poor but big pharma misses out, Chemistry World, RSC, July 25, 2012
ACTA Down, but What Next?, Express Pharma, July 18, 2012
US steps up lobbying efforts against compulsory licensing, Live Mint (WSJ), July 17, 2012
Strong medicine, Time of India, Crest Edition, July 14, 2012
India to give free medicine to hundreds of millions, Deccan Herald, July 5, 2012
FIPB may be allowed to clear foreign buys in pharma companies, Economic Times, May 16, 2012
Pharma companies open to milder alternative pricing mechanism, Economic Times, May 16, 2012
Probe finds collusion between drug regulator, pharma firms, Deccan Herald, May 10, 2012
Health panel rap to drug regulator, boost for consumers, Hindu Business Line, May 9, 2012
Probe finds collusion between drug regulator, pharma firms, First Post, May 9, 2012
Indian drug regulator accused of malpractice, Financial Times, London, May 9, 2012
Unclear rules stop FDI in pharma companies, Economic Times, May 8, 2012
Natco gets India’s first compulsory licence, Live Mint (WSJ), March 13, 2012
Natco Pharma bags licence to sell Bayer’s cancer drug Nexavar, Economic Times, March 13, 2012
MNCs circle, descend on Indian vaccine market, Business Standard, March 11, 2012
Bulk drugs should remain under price control, say pharma MNCs, Financial Express, December 17, 2011
Rs.3,000 crore loss to industry if draft drug policy implemented, LiveMint (WSJ), December 6, 2011
New policy to force cut in imported drug prices, Economic Times, November 3, 2011
Delay in CCI as regulator for pharma deals irks MNCs, Financial Express, October 24, 2011
Ministry proposal on FDI cap in pharma sector faces criticism, LiveMint (WSJ), September 23, 2011
MNC drug-makers allay fears of rise in prices, The Hindu Business Line, August 3, 2011,
Kurian quits as Patent Office Chief,LiveMint (WSJ),June 15, 2011
Strong dose: Govt ay make pharma code mandatory, Times of India, June 7, 2011
Government drafts official code of marketing practices for pharma industry,
Economic Times, June 4, 2011
Details of patented drugs to be made public,
Live Mint (WSJ), May 23, 2011
HELP IN THE HOUR OF NEED,
Express Pharma, April 1-15, 2011
Pharma FDI over 49% may need FIPB nod;
The Financial Express, Tue, 5 Apr 2011
Foreign takeovers of Indian drug companies fuel fear of rising prices;
The Washington Post. March 11, 2011
Natco seeks Pfizer nod for drug clone,
The Economic Times, January 5, 2011
New pharma policy to focus on cheaper drugs for poor,
Financial Express, December 15, 2010
US trade representative finds fault with India, China intellectual property regimes,
Livemint, Nov 24, 2010
Pharma Leaders Shine At Nation’s Biggest Leadership Meet & Awards,
June 29, 2010
US Healthcare Reforms to aid BPOs,
Hindustan Times, June 26, 2010
Credibility crisis looms as Indian medical council is dissolved,
Scrip, 18 May 2010
OPPI upset over poor cold room storage facility at airports,
Pharmabiz, May 7, 2010
Bionomics of biosimilars – Indian opportunities,
May 5, 2010
World IP Day,
ITAG. April 26, 2010
Cipla offers govt low-cost drug technology to fight cancer, AIDS,
Live Mint (WSJ). April 21, 2010
4th Health & Youth Conference,
J.W. Marriott Hotel, Seoul, Korea, April 15, 2010
Indian Pharmaceutical Alliance Defends Section 3(d) Of Patents Act, Says Statute Not Against Incremental Innovations ,
PharmAsia News, Bio-Pharma Today April 7, 2010
Pfizer, Novartis and Eli Lilly got bulk of contentious patents,
Live Mint (WSJ). April 6, 2010
A balanced budget, but not much for pharma,
Express Pharma. March 16-31, 2010
Indian ethics code: Will industry self-regulation suffice?
Scrip, 19 March 2010
Indian ethics code: Will industry self-regulation suffice?
Scrip, 19 March 2010
Pharma biggies disclose payments made to doctors ctors,
Times of India, 1-February-2010
Pharma firms reveal payments to doctors,
Times of India, 1-February-2010
Bionomics of Biosimilars,
Biospectrum, January 13, 2010
Small pharma cos oppose self-regulation for industry, want rules,
The Economic Times, December 11, 2009
Breaking an unholy alliance,
The Telegraph, November 23, 2009
Doctorss told not to accept gifts from drug companies,
The Economic Times, November 16, 2009
Prescriptions Without Motives,
Businessworld, November 16, 2009
Generics Gateway,
November 09, 2009
Low imports from China lead to 15% shortage in drugs,
DNA, November 6, 2009
Opportunities and challenges in the health marketing space,
The Times of India, October 14, 2009
FIRST ALCAN PACKAGING UNIVERSITY IN INDIA,
October 5, 2009
Patent experts pool being set up to advise courts
Board of Directors Shasun (SCDL)
Indian industry divided over review of 86 patents.pdf
IIPS Advisory Board, NMIMS University
New ‘cold chain’ facility for Delhi airport
Cambridge-India Partnership, University of Cambridge, February, 2009
Delhi HC directs DCGI not to permit generic drugmakers for drugs already patented
Business, India Infoline News Service / Mumbai Dec 16, 2008
Pharma families of India -Towards a new dawn
DCGIs plan on patent linkage gets HC booster
Relax export norms to tap global clinical R&D market.pdf
Pharma MNCs ask DCGI to liaison with patent offices.pdf
OPPI, IDMA come out with contrasting views on definition of counterfeit drugs.pdf
Chineese move queers pharma pitc, DNA Money, July 27, 2008
OPPI seeks 6-month deadline for pre-grant oppositions.pdf
OPPI Appoints Imprimis PR As Its Communications Partner.pdf
Ocimum Biosolutions CEO wins Astia and Biospectrum awards.pdf
No relief for cancer patients-drugs still cost more in India.pdf
More knocks than praise as transparency remains key issue.pdf
MNC pharma firms told to launch latest drugs in India.pdf
India, China pharma cos need to leverage knowledge capital.pdf
Govt may use compulsory licensing for drug companies only in emergency.pdf
Faster drug price revision booster shot for pharma.pdf
Ex parte order to Bristol-Myers setback to Indian drug industry.pdf
Drug firms may stop freebies to doctors.pdf
DCGI’s plan to patent linkage gets HC booster.pdf
Ocimum Biosolutions CEO wins Astia and Biospectrum awards. Indiainfoline, December 16, 2008
Healthcare and Pharma Conclave, Indian School of Business (ISB) September 26-27, 2008
Are your drugs boosting your doctor’s lifestyle? December 15, 2008
No relief for cancer patients—drugs still cost more in India. Mint, June 28, 2008
Hijack At Pill Point. May 19, 2008
Budget 2008-09 satisfactory, says industry.pdf
Members of Council, IFPMA, Geneva, Switzerland
Abbot launches health drink, Business Line, Thursday, March 30, 2000